OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy
Cristina Barca, Christoph M. Griessinger, Andreas Faust, et al.
Pharmaceuticals (2021) Vol. 15, Iss. 1, pp. 13-13
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer
Ute Hennrich, Matthias Eder
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1292-1292
Open Access | Times Cited: 148

Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
Fang-Ying Chiu, Yun Yen
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 37

Current Advances in PARP1‐Targeted Theranostics
Jie Tong, Baosheng Chen, Tommaso Volpi, et al.
Journal of Labelled Compounds and Radiopharmaceuticals (2025) Vol. 68, Iss. 1-2
Closed Access | Times Cited: 1

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
Holis Abdul Holik, Faisal Maulana Ibrahim, Angela Alysia Elaine, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3062-3062
Open Access | Times Cited: 37

The Future of (Radio)‐Labeled Compounds in Research and Development within the Life Science Industry
Volker Derdau, Charles S. Elmore, Thomas Härtung, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 52
Open Access | Times Cited: 17

RNA nanostructures for targeted drug delivery and imaging
Laura Teodori, Marjan Omer, Jørgen Kjems
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-19
Open Access | Times Cited: 7

Microfluidic synthesis of radiotracers: recent developments and commercialization prospects
Mark Mc Veigh, Leon M. Bellan
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1226-1243
Open Access | Times Cited: 6

⁶⁸Ga/¹⁷⁷Lu-Labeled Theranostic Pair for Targeting Fibroblast Activation Protein with Improved Tumor Uptake and Retention
Jiawen Huang, Xiaojun Zhang, Qingxing Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17785-17795
Closed Access | Times Cited: 6

Exploring innovative strides in radiolabeled nanoparticle progress for multimodality cancer imaging and theranostic applications
Atena Najdian, Davood Beiki, Milad Abbasi, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Optimized production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair for nuclear medicine
Brooke L. McNeil, Simona A. Mastroianni, Scott McNeil, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13

Radiochemistry: A Hot Field with Opportunities for Cool Chemistry
Gregory D. Bowden, Peter J. H. Scott, Eszter Boros
ACS Central Science (2023) Vol. 9, Iss. 12, pp. 2183-2195
Open Access | Times Cited: 12

Brain metastasis: An insight into novel molecular targets for theranostic approaches
Liliana Santos, João Nuno Moreira, Antero Abrunhosa, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104377-104377
Open Access | Times Cited: 4

A review of recent advances in the modeling of nanoparticle radiosensitization with the Geant4-DNA toolkit
Ali Taheri, Mayeen Uddin Khandaker, F. Moradi, et al.
Radiation Physics and Chemistry (2023) Vol. 212, pp. 111146-111146
Closed Access | Times Cited: 11

PSMA-GCK01: A Generator-Based^99mTc/¹⁸⁸Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
Jens Cardinale, Frederik L. Giesel, Christina Wensky, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 7, pp. 1069-1075
Open Access | Times Cited: 10

Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling
Aryan Golzaryan, M. Soltani, Farshad Moradi Kashkooli, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Nanotechnology-Assisted Cell Tracking
Alessia Peserico, Chiara Di Berardino, Valentina Russo, et al.
Nanomaterials (2022) Vol. 12, Iss. 9, pp. 1414-1414
Open Access | Times Cited: 16

3p-C-NETA: A versatile and effective chelator for development of Al¹⁸F-labeled and therapeutic radiopharmaceuticals
Stephen Ahenkorah, Erika Murce, Christopher Cawthorne, et al.
Theranostics (2022) Vol. 12, Iss. 13, pp. 5971-5985
Open Access | Times Cited: 15

Druggability of Targets for Diagnostic Radiopharmaceuticals
Xinyu Wang, Chongyang Chen, Junjie Yan, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 8, pp. 1107-1119
Open Access | Times Cited: 7

A Theranostic Nanocomplex Combining with Magnetic Hyperthermia for Enhanced Accumulation and Efficacy of pH-Triggering Polymeric Cisplatin(IV) Prodrugs
Yang Qu, Zhiqi Wang, Miao Sun, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 480-480
Open Access | Times Cited: 11

Interaction of Radiopharmaceuticals with Somatostatin Receptor 2 Revealed by Molecular Dynamics Simulations
Silvia Gervasoni, I. Çetin Öztürk, Camilla Guccione, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4924-4933
Open Access | Times Cited: 5

Efficiency of 124I radioisotope production from natural and enriched tellurium dioxide using 124Te(p,xn)124I reaction
Paweł Bzowski, Damian Borys, Kamil Gorczewski, et al.
EJNMMI Physics (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 8

Cancer Theranostics: Pharmaceutical View
Gayathri Rajaram, Alagumurugan Alagaraswamy, Muthukumar Subramanian, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 1

Navigating the landscape of theranostics in nuclear medicine: current practice and future prospects
Aayushi C. Shah, Akshada S. Dabhade, Hetvi Bharadia, et al.
Zeitschrift für Naturforschung C (2024) Vol. 79, Iss. 9-10, pp. 235-266
Closed Access | Times Cited: 1

Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications
Mazen Abdulrahman Binmujlli
Molecules (2024) Vol. 29, Iss. 17, pp. 4203-4203
Open Access | Times Cited: 1

Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers
Martina Sollini, Jérémie Calais, Arturo Chiti, et al.
European Urology (2024)
Closed Access | Times Cited: 1

Page 1 - Next Page

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 1-25 of 42 citing articles:

Your Privacy